Twitter YouTube LinkedIn

Diagnos Inc.

Disclaimer: All stock information on InvestorIntel.com is currently being fed from multiple sources and is updated automatically every 10-minutes. The information on this site is for information purposes only and InvestorIntel Corp. is neither responsible nor liable for the accuracy of this data.

InvestorIntel Features on Diagnos Inc.

Andre Larente speaks to Mario Drolet about the importance of the DIAGNOS agreement with IRIS

In a recent InvestorIntel interview, Mario Drolet speaks with André Larente, President of Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF) […]

Agreement with IRIS a ‘major breakthrough’ for DIAGNOS path to global commercialization

Did you know that doctors can study the retina of your eye and get an early reading on the condition […]

Diagnos’ André Larente on Entering the DACH and Central European Healthcare Market

In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente President of Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF) […]

Company Overview

Team | Website

DIAGNOS is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its FLAIRE Artificial Intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications such as CARA (Computer Assisted Retina Analysis). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients. CARA has been cleared for commercialization by the following regulators: Health Canada, the FDA (USA), CE (Europe), COFEPRIS (Mexico) and Saudi FDA (Saudi Arabia).

News Releases

View All News

Twitter LinkedIn YouTube Amazon Alexa iTune Podcast Google Podcasts Spotify